DECIPHERING DRUG RESISTANCE MECHANISMS IN TRIPLE-NEGATIVE BREAST CANCER THROUGH CROSS-PLATFORM INTEGRATION OF SCRNA-SEQ,EPIGENOMICS, AND CHEMOINFORMATICSINTRODUCTION. CHRE 2024, 2 (01), 64-85.